MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturities of investments
$252,858K
Net cash provided by
(used in) investing...
$113,020K
Canceled cashflow
$139,838K
Net (decrease)
increase in cash, cash...
-$3,330K
Canceled cashflow
$113,020K
Stock-based compensation
$12,517K
Amortization of debt-related
costs
$1,700K
Decrease (increase) in
prepaid expenses and...
-$1,532K
Decrease (increase) in
accounts receivable
-$1,089K
Decrease in other
long-term assets
-$757K
Depreciation and
amortization
$621K
Proceeds from issuance of
common stock for equity...
$73K
Purchases of investments
$139,838K
Net cash used in
operating activities
-$67,851K
Canceled cashflow
$18,216K
Net cash (used in)
provided by financing...
-$48,499K
Canceled cashflow
$73K
Net loss
-$50,341K
(decrease) increase in
accounts payable and...
-$30,222K
Accretion of marketable
securities purchased at a...
$3,712K
Other non-cash
adjustments
$1,742K
(increase) decrease in
inventories
$50K
Debt payments
$48,000K
Payments for tax
withholding on share-based...
$572K
Back
Back
Cash Flow
source: myfinsight.com
LEXICON PHARMACEUTICALS, INC. (LXRX)
LEXICON PHARMACEUTICALS, INC. (LXRX)